Evidence map›Paper›PMID 41971646›Full record

ArticleTechnical innovations & patient support in radiation oncology2026

Dosimetric comparison of the shoulder region between paired photon and proton plans in breast cancer patients.

Yuqin Liang, Karolien Verhoeven, Gloria Vilches-Freixas, Sophie C J Bosma, Richard Canters, Femke E Froklage, Ruud Houben, John H Maduro, Jelle Overbosch, Joan J Penninkhof and 7 more

Abstract read
In one paragraph

Article in Technical innovations & patient support in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yuqin LiangDepartment of Radiation Oncology (Maastro), GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Karolien VerhoevenDepartment of Radiation Oncology (Maastro), GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Gloria Vilches-FreixasDepartment of Radiation Oncology (Maastro), GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Sophie C J BosmaDepartment of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands.
Richard CantersDepartment of Radiation Oncology (Maastro), GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Femke E FroklageDepartment of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Ruud HoubenDepartment of Radiation Oncology (Maastro), GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
John H MaduroDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Jelle OverboschDepartment of Radiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Joan J PenninkhofDepartment of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Margriet G A SattlerDepartment of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Janine M SimonsDepartment of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Nanna M SijtsemaDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Rozemarijn VliegenthartDepartment of Radiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Anne P G CrijnsDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Sofia RiveraRadiation Oncology Department, Gustave Roussy, Villejuif, France.
Liesbeth J BoersmaDepartment of Radiation Oncology (Maastro), GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adjuvant radiotherapy lowers regional recurrence in breast cancer but may cause arm symptoms. We compared photon (XRT) and proton therapy (PT) doses to eight shoulder structures, including seven muscles and the axillary-lateral thoracic junction (ALTJ). Methods: We consecutively included all patients treated with PT in our centre for whom paired XRT-PT plans (2019-2024) were available. Eight shoulder structures were autodelineated with manual correction of the ALTJ region. For each parameter, medians (Q1-Q3) were calculated, and paired differences were defined as Δᵢ = XRTᵢ - PTᵢ and summarized by the median of Δᵢ for subject i; Statistical inference used the Wilcoxon signed-rank test with Hodges-Lehmann estimates (95% confidence intervals). Multiple comparisons were adjusted using the Benjamini-Hochberg procedure. Exploratory subgroup analyses were stratified by Regional nodal irradiation (RNI) levels. Analyses were performed in R (version 4.5.2). Results: In 128 paired plans, XRT delivered significantly higher doses than PT to all shoulder muscles. For the five key muscles, XRT delivered 10.0-21.1 Gy higher D Conclusion: PT offers substantial dosimetric advantages for five shoulder muscles compared with XRT. The clinical relevance of these dosimetric differences requires further study.

Identifiers

PMID41971646
PMCPMC13068848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.